IP Verse

Phosphate-Free Pharmaceutical Composition For The Treatment Of Glaucoma - EP2429507

The patent EP2429507 was granted to Ursapharm Arzneimittel on Jul 19, 2017. The application was originally filed on May 14, 2010 under application number EP10723922A. The patent is currently recorded with a legal status of "Revoked".

EP2429507

URSAPHARM ARZNEIMITTEL
Application Number
EP10723922A
Filing Date
May 14, 2010
Status
Revoked
Jan 10, 2020
Grant Date
Jul 19, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

PHARMA STULLNApr 17, 2018JORG BERTEN -

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTDE102005055275
INTERNATIONAL-SEARCH-REPORTEP1312366
INTERNATIONAL-SEARCH-REPORTEP1985298
INTERNATIONAL-SEARCH-REPORTUS2001044467
INTERNATIONAL-SEARCH-REPORTUS2005276867
INTERNATIONAL-SEARCH-REPORTUS2008021101
INTERNATIONAL-SEARCH-REPORTWO0158866
INTERNATIONAL-SEARCH-REPORTWO2008096804
INTERNATIONAL-SEARCH-REPORTWO9853809
OPPOSITIONEP1985298
OPPOSITIONEP2123278
OPPOSITIONWO2007057201
OPPOSITIONWO2008096804
OPPOSITIONWO9853809

Non-Patent Literature (NPL) Citations (13) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
EXAMINATION- R Roswell, "Sodium citrate reduces the incidence of corneal ulcerations and perforations in extreme alkali-burned eyes - acetylcysteine and ascorbate have no favorable effect", Invest. Ophthalmol. Vis. Sci, (19810901), URL: http://iovs.arvojournals.org/data/Journals/IOVS/933330/486.pdf, (20161013), XP055310640-
EXAMINATION- AHMED I ET AL, "Evaluation of buffer systems in ophthalmic product development", INTERNATIONAL JOURNAL OF PHARMACEUTICS, ELSEVIER BV, NL, vol. 44, no. 1-3, doi:10.1016/0378-5173(88)90105-6, ISSN 0378-5173, (19880601), pages 97 - 105, (19880601), XP025554378
INTERNATIONAL-SEARCH-REPORT- NORBERT FRANZ SCHRAGE ET AL, "Relationship of eye burns with calcifications of the cornea?", GRAEFE'S ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY ; INCORPORATING GERMAN JOURNAL OF OPHTHALMOLOGY, SPRINGER, BERLIN, DE LNKD- DOI:10.1007/S00417-004-1089-2, (20050801), vol. 243, no. 8, ISSN 1435-702X, pages 780 - 784, XP019342832 [A] 1-19 * the whole document *
OPPOSITION- Arthur H Kibbe, Handbook of Pharmaceutical Excipients Third Edition, Washington, (20000000), pages 140 - 142, XP055484467-
OPPOSITION- "Für den SOldaten zu Hause im Einsatz", Wehrmedizin und Wehrpharmazie, (20081201), URL: http://www.wehrmed.de/article/1852- fuer-den-soldaten-zu-hause-im-einsatz.html, XP055484436-
OPPOSITION- LAKOMY et al., "On recherche: les meilleures larmes artificielles", Schweizer Apothekerzeitung, (20060000), pages 517 - 523, XP055484453-
OPPOSITION- LEMP, "Management of Dry Eye Disease", American Journal of Managed Care, (20080400), vol. 14, pages S88 - S101, XP008175239-
OPPOSITION- PFISTER et al., "Sodium citrate reduces the incidence of corneal ulcerations and perforations in extreme alkali-burned eyees - acetylcysteine and ascorbate have no favourable effect", Invest. Ophthalmol. Vis. Sci., (19810000), vol. 490, pages 486 - 490, XP055484464-
OPPOSITION- BERNAUER, "Phosphate concentration in artificial tears", Graefe's Arch Clin Exp Ophthalmol., (20060000), vol. 244, pages 1010 - 1014, XP019426940
OPPOSITION- SCHRAGE et al., "Phosphate buffer in alkali eye burns as an inducer of experimental corneal calcification", Burns, (20010800), vol. 27, no. 5, pages 459 - 464, XP055484448
OPPOSITION- BERNAUER et al., "Phosphate Concentrations in Antiglaucoma Medication", Klin. Monatsbl. Augenheikd., (20070000), vol. 224, pages 249 - 251, XP055352657
OPPOSITION- KAUR et al., "Penetration Enhancers and Ocular Bioadhesives: Two New Avenues for Ophthalmic Drug Delivery", Drug Development and Industrial 2002 Pharmacy, (20020000), vol. 28, pages 353 - 369, XP055484424
OPPOSITION- BERNAUER et al., "Corneal calcification following intensified treatment with sodium hyaluronate artificial tears", Br J Ophthalmol, (20060000), vol. 90, pages 285 - 288, XP055484445

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents